Ligand Pharmaceuticals (LGND)

Add to Watchlists
Create an Alert
53.97 -0.16  -0.30% NASDAQ Oct 24, 8:00PM BATS Real time Currency in USD
View Full Chart
LGND Price Chart
View All Events

LGND Events

Date Type Description
11/18/2014 10:00 EDT Misc Ligand Analyst Day
10/27/2014 09:00 EDT Misc Q3 2014 Ligand Earnings Conference Call
10/27/2014 Earnings Q3 2014 Ligand Earnings Results
08/04/2014 09:00 EDT Misc Q2 2014 Ligand Pharmaceuticals Inc Earnings Conference Call
08/04/2014 Earnings Q2 2014 Ligand Pharmaceuticals Inc Earnings Results
06/04/2014 Misc Annual General Meeting for Ligand Pharmaceuticals Inc
05/07/2014 09:00 EDT Misc Q1 2014 Ligand Pharmaceuticals Inc Earnings Conference Call
05/07/2014 Earnings Q1 2014 Ligand Pharmaceuticals Inc Earnings Results
03/11/2014 Misc Ligand Announces Highlights From Presentation at the 26th Annual Roth Capital Conference
02/11/2014 09:00 EST Misc Q4 2013 Ligand Conference Call
View All Performance Charts

LGND Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Ligand Pharmaceuticals is down 4.55% over the last year vs S&P 500 Total Return up 14.46%, Amgen up 29.23%, and Metabasis Therapeutics up 140.0%.

Get Quote for

PDF Report for LGND

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download LGND Pro Report PDF
Advertisement

Portfolio Strategies Featuring LGND

Did Ligand Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

LGND Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.ligand.com
  • IR Website: http://investor.ligand.com/Investors/Investor-Overview/default.aspx
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Ligand Pharmaceuticals Inc is a biotechnology company that operates with a business model focused on developing or acquiring assets. It is engaged in development and commercialization of drugs using Captisol technology by CyDex Pharmaceuticals, Inc.

LGND Excel Add-In Codes

  • Name: =YCI("LGND","name")
  • Description: =YCI("LGND","description")
  • Sector: =YCI("LGND","sector")
  • Industry: =YCI("LGND","industry")
  • Est. Current Fiscal Year End: =YCI("LGND","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.